| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.45B | 29.18B | 29.45B | 29.61B | 32.16B | 33.73B |
| Gross Profit | 15.53B | 15.07B | 15.01B | 15.59B | 17.05B | 18.21B |
| EBITDA | 1.25B | 1.09B | 1.01B | -125.00M | 1.46B | 2.18B |
| Net Income | 375.00M | 358.00M | 136.00M | -858.00M | 671.00M | 1.65B |
Balance Sheet | ||||||
| Total Assets | 28.14B | 28.05B | 28.89B | 29.06B | 31.55B | 31.93B |
| Cash, Cash Equivalents and Short-Term Investments | 9.13B | 10.06B | 9.52B | 9.29B | 12.55B | 13.94B |
| Total Debt | 293.00M | 4.00M | 9.00M | 15.00M | 20.00M | 26.00M |
| Total Liabilities | 8.77B | 8.40B | 9.62B | 10.12B | 11.67B | 12.37B |
| Stockholders Equity | 19.37B | 19.65B | 19.27B | 18.94B | 19.88B | 19.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 704.00M | 426.00M | -1.88B | -917.00M | -1.35B |
| Operating Cash Flow | 0.00 | 830.00M | 691.00M | -877.00M | 191.00M | 1.84B |
| Investing Cash Flow | 0.00 | 2.11B | -1.90B | -1.42B | -641.00M | -3.41B |
| Financing Cash Flow | 0.00 | -112.00M | -112.00M | -112.00M | -112.00M | -3.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥8.36B | 2.45 | ― | 2.66% | 15.17% | 12.30% | |
78 Outperform | ¥15.01B | 10.54 | ― | 2.22% | 26.29% | 28.62% | |
71 Outperform | ¥86.73B | 5.42 | 6.96% | 2.98% | 1.15% | 86.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥5.85B | 13.21 | ― | 1.76% | 2.24% | ― | |
55 Neutral | ¥3.00B | 4.66 | ― | ― | 0.06% | ― | |
47 Neutral | ¥6.38B | 2.43 | ― | ― | -4.10% | ― |